review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Jennifer M Bratt | |
Nicholas J Kenyon | |||
Angela L Linderholm | |||
Amir A Zeki | |||
Gertrud U Schuster | |||
P2860 | cites work | Effect of obesity on airway inflammation: a cross-sectional analysis of body mass index and sputum cell counts | Q80505537 |
Simvastatin delivery via inhalation attenuates airway inflammation in a murine model of asthma | Q83426446 | ||
Protein tyrosine phosphatase SHP2 mediates chronic insulin-induced endothelial inflammation | Q84214741 | ||
Asymmetric dimethylarginine is increased in asthma | Q84481719 | ||
Strategic localization of heart mitochondrial NOS: a review of the evidence | Q87398529 | ||
Vitamin D and Asthma | Q22306308 | ||
Vitamin C for asthma and exercise-induced bronchoconstriction | Q24202928 | ||
Metformin activates AMP kinase through inhibition of AMP deaminase | Q24617747 | ||
Cellular and molecular mechanisms of metformin: an overview | Q27013561 | ||
Structural specificity of substrate for S-adenosylmethionine:protein arginine N-methyltransferases | Q28287683 | ||
Elevated sputum interleukin-5 and submucosal eosinophilia in obese individuals with severe asthma | Q28390947 | ||
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators | Q29615694 | ||
Arginine methylation an emerging regulator of protein function | Q29617311 | ||
An association between L-arginine/asymmetric dimethyl arginine balance, obesity, and the age of asthma onset phenotype | Q30415302 | ||
Biological Methylation: Selected Aspects | Q34008554 | ||
Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death | Q34111548 | ||
Vitamin D supplementation and body weight status: a systematic review and meta-analysis of randomized controlled trials | Q34404297 | ||
Overexpression of endothelial nitric oxide synthase suppresses features of allergic asthma in mice | Q34590666 | ||
Vitamin D and chronic lung disease: a review of molecular mechanisms and clinical studies | Q34955112 | ||
Metformin attenuates the exacerbation of the allergic eosinophilic inflammation in high fat-diet-induced obesity in mice | Q35034808 | ||
MAP kinase phosphatase 1: a novel mediator of biological effects of glucocorticoids? | Q35170052 | ||
Diabetes-induced vascular dysfunction involves arginase I | Q35906453 | ||
S-glutathionylation uncouples eNOS and regulates its cellular and vascular function. | Q36017535 | ||
Obesity: insight into the origins of asthma | Q36134850 | ||
Vitamin A and retinoic acid in T cell-related immunity | Q36317116 | ||
Rho GTPases, statins, and nitric oxide | Q36336914 | ||
Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA. | Q36381003 | ||
Protein kinase C-β contributes to impaired endothelial insulin signaling in humans with diabetes mellitus | Q36610687 | ||
Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits. | Q36731862 | ||
Arginase promotes skeletal muscle arteriolar endothelial dysfunction in diabetic rats | Q36854784 | ||
The opposing effects of n-3 and n-6 fatty acids | Q37058217 | ||
Statin use and asthma control in patients with severe asthma | Q37117288 | ||
Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond | Q37423130 | ||
Association between antioxidant vitamins and asthma outcome measures: systematic review and meta-analysis | Q37465839 | ||
Overexpression of dimethylarginine dimethylaminohydrolase 1 attenuates airway inflammation in a mouse model of asthma | Q37490288 | ||
Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury | Q37542333 | ||
Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease | Q37734257 | ||
The role of L-arginine in the prevention and treatment of pre-eclampsia: a systematic review of randomised trials | Q38156527 | ||
Acute simvastatin increases endothelial nitric oxide synthase phosphorylation via AMP-activated protein kinase and reduces contractility of isolated rat mesenteric resistance arteries. | Q38450680 | ||
Metformin reduces airway inflammation and remodeling via activation of AMP-activated protein kinase | Q38457681 | ||
Arginase I and the very low-density lipoprotein receptor are associated with phenotypic biomarkers for obesity | Q38467212 | ||
Arginase inhibition in airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin. | Q39287243 | ||
AMPK agonists ameliorate sodium and fluid transport and inflammation in cystic fibrosis airway epithelial cells | Q41419182 | ||
Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis | Q41472157 | ||
Simvastatin inhibits goblet cell hyperplasia and lung arginase in a mouse model of allergic asthma: a novel treatment for airway remodeling? | Q41557551 | ||
Diabetes-induced coronary vascular dysfunction involves increased arginase activity | Q41817278 | ||
Nitric oxide synthase enzymes in the airways of mice exposed to ovalbumin: NOS2 expression is NOS3 dependent | Q41891749 | ||
Increased arginase activity underlies allergen-induced deficiency of cNOS-derived nitric oxide and airway hyperresponsiveness | Q42126686 | ||
Differential effects of simvastatin on IL-13-induced cytokine gene expression in primary mouse tracheal epithelial cells | Q42326095 | ||
Effect of Oral Arginine Supplementation on Exhaled Nitric Oxide Concentration in Sickle Cell Anemia and Acute Chest Syndrome | Q42931726 | ||
Direct inhibition of arginase attenuated airway allergic reactions and inflammation in a Dermatophagoides farinae-induced NC/Nga mouse model | Q43103711 | ||
Beneficial effects of high dose of L-arginine on airway hyperresponsiveness and airway inflammation in a murine model of asthma | Q43163405 | ||
Inhibition of geranylgeranyltransferase inhibits bronchial smooth muscle hyperresponsiveness in mice | Q43283584 | ||
Altered asymmetric dimethyl arginine metabolism in allergically inflamed mouse lungs | Q43300073 | ||
Dietary antioxidants and ozone-induced bronchial hyperresponsiveness in adults with asthma | Q43692513 | ||
PKA inhibits RhoA activation: a protection mechanism against endothelial barrier dysfunction | Q43712800 | ||
Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus | Q43796150 | ||
Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor | Q43922999 | ||
Oral atorvastatin therapy restores cutaneous microvascular function by decreasing arginase activity in hypercholesterolaemic humans | Q44298564 | ||
Serum fatty acid levels, dietary style and coronary heart disease in three neighbouring areas in Japan: the Kumihama study | Q44307887 | ||
Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells | Q44468960 | ||
Inhibition of inflammation and remodeling by roflumilast and dexamethasone in murine chronic asthma | Q44572920 | ||
Decreased arginine bioavailability and increased serum arginase activity in asthma | Q44834866 | ||
Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species | Q44987425 | ||
Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine | Q45161752 | ||
Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction | Q45166632 | ||
Lovastatin inhibits antigen-induced airway eosinophilia without affecting the production of inflammatory mediators in mice. | Q46024300 | ||
Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma. | Q46087998 | ||
Vitamin A status is associated with T-cell responses in Bangladeshi men. | Q46131263 | ||
Statins activate AMP-activated protein kinase in vitro and in vivo | Q46230916 | ||
Efficacy and safety of oral l-arginine in acute myocardial infarction. Results of the multicenter, randomized, double-blind, placebo-controlled ARAMI pilot trial. | Q46521221 | ||
Exhaled nitric oxide estimation by a simple and efficient noninvasive technique and its utility as a marker of airway inflammation in mice | Q47904927 | ||
Adiposity, asthma, and airway inflammation | Q50090203 | ||
The associations of a marine diet with plasma lipids, blood glucose, blood pressure and obesity among the inuit in Greenland. | Q51553540 | ||
Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5' adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway. | Q54380805 | ||
cAMP phosphodiesterase inhibitors increases nitric oxide production by modulating dimethylarginine dimethylaminohydrolases. | Q54384259 | ||
AMP-activated kinase relaxes agonist induced contractions in the mouse aorta via effects on PKC signaling and inhibits NO-induced relaxation. | Q54488408 | ||
YC-1 potentiates cAMP-induced CREB activation and nitric oxide production in alveolar macrophages. | Q54526168 | ||
Increased arginase activity contributes to airway remodelling in chronic allergic asthma | Q57099007 | ||
Fluid Shear Stress and NO Decrease the Activity of the Hydroxy-Methylglutaryl Coenzyme A Reductase in Endothelial Cells via the AMP-Activated Protein Kinase and FoxO1 | Q60760123 | ||
Analysis of methylarginine metabolism in the cardiovascular system identifies the lung as a major source of ADMA | Q61911220 | ||
Simvastatin Improves Epithelial Dysfunction and Airway Hyperresponsiveness | Q62802978 | ||
Phosphorylation and inactivation of HMG-CoA reductase at the AMP-activated protein kinase site in response to fructose treatment of isolated rat hepatocytes | Q68203468 | ||
Mevalonate pathway and isoprenoids regulate human bronchial myocyte proliferation | Q70911484 | ||
Differential systemic and pulmonary hemodynamic effects of L-arginine in patients with coronary artery disease or primary pulmonary hypertension | Q71670308 | ||
Reduction of matrix metalloproteinase-9 activity by the selective phosphodiesterase 4 inhibitor, RP 73-401 in sensitized mice | Q74341896 | ||
Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin | Q79955135 | ||
P433 | issue | 4 | |
P921 | main subject | obesity | Q12174 |
asthma | Q35869 | ||
P304 | page(s) | 809-823 | |
P577 | publication date | 2014-08-29 | |
P1433 | published in | Immunology and Allergy Clinics of North America | Q2420699 |
P1476 | title | Novel therapeutic strategies for adult obese asthmatics | |
P478 | volume | 34 |
Q35179339 | Asthma and metabolic syndrome: Current knowledge and future perspectives. |
Q97073581 | Asthma and metabolic syndrome: a comprehensive systematic review and meta-analysis of observational studies |
Q38841393 | Could simvastatin be considered as a potential therapy for chronic lung diseases? A debate on the pros and cons. |
Q39397467 | Glucagon-like peptide 1: A potential anti-inflammatory pathway in obesity-related asthma. |
Search more.